首页 > 最新文献

Endocrinologia Y Nutricion最新文献

英文 中文
Statement on the current treatment of severe obesity in Spain 关于西班牙目前严重肥胖治疗的声明
Pub Date : 2016-12-01 DOI: 10.1016/j.endoen.2016.08.011
Felipe Casanueva , Felipe de la Cruz Vigo , Albert Goday , Juan Carlos Ruiz de Adana , Susana Monereo , Ramón Vilallonga , Purificación Martínez de Icaya , Raquel Sánchez-Santos , José Manuel García Almeida , Ismael Díez del Val
{"title":"Statement on the current treatment of severe obesity in Spain","authors":"Felipe Casanueva , Felipe de la Cruz Vigo , Albert Goday , Juan Carlos Ruiz de Adana , Susana Monereo , Ramón Vilallonga , Purificación Martínez de Icaya , Raquel Sánchez-Santos , José Manuel García Almeida , Ismael Díez del Val","doi":"10.1016/j.endoen.2016.08.011","DOIUrl":"https://doi.org/10.1016/j.endoen.2016.08.011","url":null,"abstract":"","PeriodicalId":48670,"journal":{"name":"Endocrinologia Y Nutricion","volume":"63 10","pages":"Pages 573-574"},"PeriodicalIF":0.0,"publicationDate":"2016-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.endoen.2016.08.011","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72056040","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Is diabetes mellitus correctly registered and classified in primary care? A population-based study in Catalonia, Spain 糖尿病在初级保健中的登记和分类是否正确?西班牙加泰罗尼亚的一项基于人群的研究
Pub Date : 2016-11-01 DOI: 10.1016/j.endoen.2016.10.005
Manel Mata-Cases , Dídac Mauricio , Jordi Real , Bonaventura Bolíbar , Josep Franch-Nadal

Objective

To assess the prevalence of miscoding, misclassification, misdiagnosis and under-registration of diabetes mellitus (DM) in primary health care in Catalonia (Spain), and to explore use of automated algorithms to identify them.

Methods

In this cross-sectional, retrospective study using an anonymized electronic general practice database, data were collected from patients or users with a diabetes-related code or from patients with no DM or prediabetes code but treated with antidiabetic drugs (unregistered DM). Decision algorithms were designed to classify the true diagnosis of type 1 DM (T1DM), type 2 DM (T2DM), and undetermined DM (UDM), and to classify unregistered DM patients treated with antidiabetic drugs.

Results

Data were collected from a total of 376,278 subjects with a DM ICD-10 code, and from 8707 patients with no DM or prediabetes code but treated with antidiabetic drugs. After application of the algorithms, 13.9% of patients with T1DM were identified as misclassified, and were probably T2DM; 80.9% of patients with UDM were reclassified as T2DM, and 19.1% of them were misdiagnosed as DM when they probably had prediabetes. The overall prevalence of miscoding (multiple codes or UDM) was 2.2%. Finally, 55.2% of subjects with unregistered DM were classified as prediabetes, 35.7% as T2DM, 8.5% as UDM treated with insulin, and 0.6% as T1DM.

Conclusions

The prevalence of inappropriate codification or classification and under-registration of DM is relevant in primary care. Implementation of algorithms could automatically flag cases that need review and would substantially decrease the risk of inappropriate registration or coding.

目的评估加泰罗尼亚(西班牙)初级卫生保健中糖尿病(DM)的错误编码、错误分类、误诊和登记不足的发生率,并探索使用自动化算法来识别它们。方法在这项使用匿名电子全科医学数据库的横断面回顾性研究中,数据来自具有糖尿病相关代码的患者或用户,或来自没有糖尿病或糖尿病前期代码但使用抗糖尿病药物治疗的患者(未注册糖尿病患者)。设计决策算法对1型糖尿病(T1DM)、2型糖尿病(T2DM)和未确诊糖尿病(UDM)的真实诊断进行分类,并对接受抗糖尿病药物治疗的未登记糖尿病患者进行分类。结果收集了376278名具有糖尿病ICD-10代码的受试者和8707名没有糖尿病或糖尿病前期代码但接受抗糖尿病药物治疗的患者的数据。应用算法后,13.9%的T1DM患者被确定为错误分类,可能是T2DM;80.9%的UDM患者被重新归类为T2DM,19.1%的患者在可能患有糖尿病前期时被误诊为DM。错误编码(多重编码或UDM)的总患病率为2.2%。最后,55.2%的未登记糖尿病受试者被归类为糖尿病前期,35.7%被归类为T2DM,8.5%被归类为胰岛素治疗的UDM,0.6%被归类为T1DM。结论DM编码或分类不当和登记不足的患病率与初级保健有关。算法的实现可以自动标记需要审查的案例,并将大大降低不适当注册或编码的风险。
{"title":"Is diabetes mellitus correctly registered and classified in primary care? A population-based study in Catalonia, Spain","authors":"Manel Mata-Cases ,&nbsp;Dídac Mauricio ,&nbsp;Jordi Real ,&nbsp;Bonaventura Bolíbar ,&nbsp;Josep Franch-Nadal","doi":"10.1016/j.endoen.2016.10.005","DOIUrl":"https://doi.org/10.1016/j.endoen.2016.10.005","url":null,"abstract":"<div><h3>Objective</h3><p>To assess the prevalence of miscoding, misclassification, misdiagnosis and under-registration of diabetes mellitus (DM) in primary health care in Catalonia (Spain), and to explore use of automated algorithms to identify them.</p></div><div><h3>Methods</h3><p>In this cross-sectional, retrospective study using an anonymized electronic general practice database, data were collected from patients or users with a diabetes-related code or from patients with no DM or prediabetes code but treated with antidiabetic drugs (unregistered DM). Decision algorithms were designed to classify the true diagnosis of type 1 DM (T1DM), type 2 DM (T2DM), and undetermined DM (UDM), and to classify unregistered DM patients treated with antidiabetic drugs.</p></div><div><h3>Results</h3><p>Data were collected from a total of 376,278 subjects with a DM ICD-10 code, and from 8707 patients with no DM or prediabetes code but treated with antidiabetic drugs. After application of the algorithms, 13.9% of patients with T1DM were identified as misclassified, and were probably T2DM; 80.9% of patients with UDM were reclassified as T2DM, and 19.1% of them were misdiagnosed as DM when they probably had prediabetes. The overall prevalence of miscoding (multiple codes or UDM) was 2.2%. Finally, 55.2% of subjects with unregistered DM were classified as prediabetes, 35.7% as T2DM, 8.5% as UDM treated with insulin, and 0.6% as T1DM.</p></div><div><h3>Conclusions</h3><p>The prevalence of inappropriate codification or classification and under-registration of DM is relevant in primary care. Implementation of algorithms could automatically flag cases that need review and would substantially decrease the risk of inappropriate registration or coding.</p></div>","PeriodicalId":48670,"journal":{"name":"Endocrinologia Y Nutricion","volume":"63 9","pages":"Pages 440-448"},"PeriodicalIF":0.0,"publicationDate":"2016-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.endoen.2016.10.005","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72027622","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Autosomal dominant hypocalcaemia: A novel mutation 常染色体显性低钙血症:一种新的突变
Pub Date : 2016-11-01 DOI: 10.1016/j.endoen.2016.10.013
Lidia Urbón López de Linares , Cristina Crespo Soto , Luis Cuellar Olmedo , Maria Piedra León
{"title":"Autosomal dominant hypocalcaemia: A novel mutation","authors":"Lidia Urbón López de Linares ,&nbsp;Cristina Crespo Soto ,&nbsp;Luis Cuellar Olmedo ,&nbsp;Maria Piedra León","doi":"10.1016/j.endoen.2016.10.013","DOIUrl":"https://doi.org/10.1016/j.endoen.2016.10.013","url":null,"abstract":"","PeriodicalId":48670,"journal":{"name":"Endocrinologia Y Nutricion","volume":"63 9","pages":"Pages 505-506"},"PeriodicalIF":0.0,"publicationDate":"2016-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.endoen.2016.10.013","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72038276","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An update on probiotics, prebiotics and symbiotics in clinical nutrition 益生菌、益生元和共生素在临床营养学中的最新进展
Pub Date : 2016-11-01 DOI: 10.1016/j.endoen.2016.10.011
Gabriel Olveira , Inmaculada González-Molero

The concept of prebiotics, probiotics, and symbiotics and their use in different situations of daily clinical practice related to clinical nutrition is reviewed, as well as their role in the treatment/prevention of diarrhea (acute, induced by antibiotics, secondary to radiotherapy), inflammatory bowel disease (ulcerative colitis and pouchitis), in colonic health (constipation, irritable bowel), in liver disease (steatosis and minimum encephalopathy), and in intensive care, surgical, and liver transplantation. While their effectiveness for preventing antibiotic-induced diarrhea and pouchitis in ulcerative colitis appears to be shown, additional studies are needed to establish recommendations in most clinical settings. The risk of infection associated to use of probiotics is relatively low; however, there are selected groups of patients in whom they should be used with caution (as jejunum infusion).

综述了益生元、益生菌和共生素的概念及其在与临床营养相关的日常临床实践中的不同情况下的应用,以及它们在治疗/预防腹泻(急性、抗生素诱导、放疗后继发)、炎症性肠病(溃疡性结肠炎和pouchitis)、结肠健康(便秘、肠易激综合征),在肝病(脂肪变性和轻度脑病)、重症监护、外科手术和肝移植中。虽然它们在预防抗生素诱导的腹泻和溃疡性结肠炎中的pouchitis方面的有效性似乎得到了证明,但还需要进行更多的研究,以在大多数临床环境中建立建议。与使用益生菌相关的感染风险相对较低;然而,有一些选定的患者组应该谨慎使用它们(如空肠输注)。
{"title":"An update on probiotics, prebiotics and symbiotics in clinical nutrition","authors":"Gabriel Olveira ,&nbsp;Inmaculada González-Molero","doi":"10.1016/j.endoen.2016.10.011","DOIUrl":"https://doi.org/10.1016/j.endoen.2016.10.011","url":null,"abstract":"<div><p>The concept of prebiotics, probiotics, and symbiotics and their use in different situations of daily clinical practice related to clinical nutrition is reviewed, as well as their role in the treatment/prevention of diarrhea (acute, induced by antibiotics, secondary to radiotherapy), inflammatory bowel disease (ulcerative colitis and pouchitis), in colonic health (constipation, irritable bowel), in liver disease (steatosis and minimum encephalopathy), and in intensive care, surgical, and liver transplantation. While their effectiveness for preventing antibiotic-induced diarrhea and pouchitis in ulcerative colitis appears to be shown, additional studies are needed to establish recommendations in most clinical settings. The risk of infection associated to use of probiotics is relatively low; however, there are selected groups of patients in whom they should be used with caution (as jejunum infusion).</p></div>","PeriodicalId":48670,"journal":{"name":"Endocrinologia Y Nutricion","volume":"63 9","pages":"Pages 482-494"},"PeriodicalIF":0.0,"publicationDate":"2016-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.endoen.2016.10.011","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72027625","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pituitary adenoma associated with pheochromocytoma/paraganglioma: A new form of multiple endocrine neoplasia 垂体腺瘤伴嗜铬细胞瘤/副神经节瘤:一种新型的多发性内分泌肿瘤
Pub Date : 2016-11-01 DOI: 10.1016/j.endoen.2016.10.012
Fernando Guerrero Pérez , Arturo Lisbona Gil , Mercedes Robledo , Pedro Iglesias , Carles Villabona Artero
{"title":"Pituitary adenoma associated with pheochromocytoma/paraganglioma: A new form of multiple endocrine neoplasia","authors":"Fernando Guerrero Pérez ,&nbsp;Arturo Lisbona Gil ,&nbsp;Mercedes Robledo ,&nbsp;Pedro Iglesias ,&nbsp;Carles Villabona Artero","doi":"10.1016/j.endoen.2016.10.012","DOIUrl":"https://doi.org/10.1016/j.endoen.2016.10.012","url":null,"abstract":"","PeriodicalId":48670,"journal":{"name":"Endocrinologia Y Nutricion","volume":"63 9","pages":"Pages 506-508"},"PeriodicalIF":0.0,"publicationDate":"2016-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.endoen.2016.10.012","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72038275","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The specific immunotherapy of autoimmune diseases through the nanomedicine 纳米药物对自身免疫性疾病的特异性免疫治疗
Pub Date : 2016-11-01 DOI: 10.1016/j.endoen.2016.10.007
Joan Verdaguer
{"title":"The specific immunotherapy of autoimmune diseases through the nanomedicine","authors":"Joan Verdaguer","doi":"10.1016/j.endoen.2016.10.007","DOIUrl":"https://doi.org/10.1016/j.endoen.2016.10.007","url":null,"abstract":"","PeriodicalId":48670,"journal":{"name":"Endocrinologia Y Nutricion","volume":"63 9","pages":"Pages 437-439"},"PeriodicalIF":0.0,"publicationDate":"2016-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.endoen.2016.10.007","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72027611","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Incidental versus non-incidental thyroid carcinoma: Clinical presentation, surgical management and prognosis 偶发与非偶发甲状腺癌的临床表现、手术治疗和预后
Pub Date : 2016-11-01 DOI: 10.1016/j.endoen.2016.10.008
Elena González-Sánchez-Migallón , Benito Flores-Pastor , Carmen Victoria Pérez-Guarinos , Joana Miguel-Perelló , Asunción Chaves-Benito , Fátima Illán-Gómez , Andrés Carrillo-Alcaraz , José Luis Aguayo-Albasini

Background and objective

Thyroid cancer may be clinically evident as a tumor mass in the neck or as a histopathological incidental finding after thyroid surgery for an apparent benign condition. Our objective was to assess the differences in clinical signs, surgical management, and course between incidental and clinically diagnosed thyroid tumors.

Methods

A retrospective study was conducted on patients operated on for benign or malignant thyroid disease from January 2000 to March 2014. Among the 1415 patients who underwent any thyroid surgery, 264 neoplasms were found, of which 170 were incidental. A comparison was made of incidental versus non-incidental carcinomas. Among incidental carcinomas, cases whose indication for surgery was Graves’ disease were compared to those with multinodular goiter.

Results

Incidental carcinomas were in earlier stages and required less aggressive surgery. There were no differences in surgical complications between incidental and clinical tumors, but mortality and relapses were markedly higher in non-incidental cancers (4.4% vs 0% and 13.2% vs 4.8% respectively). Carcinomas developing on Graves’ disease showed no differences from all other incidental tumors in terms of complications, mortality, or relapse after surgery.

Conclusions

Early stage thyroid cancer has better survival and prognosis after surgical treatment.

背景与目的甲状腺癌症可能是临床上明显的颈部肿块,或是甲状腺手术后的组织病理学偶然发现的明显良性病变。我们的目的是评估偶发和临床诊断的甲状腺肿瘤在临床症状、手术治疗和病程方面的差异。方法对2000年1月至2014年3月甲状腺良恶性疾病手术患者进行回顾性研究。在接受任何甲状腺手术的1415名患者中,发现264个肿瘤,其中170个是偶然发生的。对偶发癌和非偶发癌进行了比较。在偶发癌中,将手术指征为Graves病的病例与多结节性甲状腺肿的病例进行比较。结果偶发性癌发生在早期,需要较少的手术治疗。偶发性肿瘤和临床肿瘤的手术并发症没有差异,但非偶发性癌症的死亡率和复发率明显更高(分别为4.4%vs 0%和13.2%vs 4.8%)。Graves病上发生的癌症在并发症、死亡率或术后复发方面与所有其他偶发肿瘤没有差异。结论早期癌症经手术治疗后有较好的生存率和预后。
{"title":"Incidental versus non-incidental thyroid carcinoma: Clinical presentation, surgical management and prognosis","authors":"Elena González-Sánchez-Migallón ,&nbsp;Benito Flores-Pastor ,&nbsp;Carmen Victoria Pérez-Guarinos ,&nbsp;Joana Miguel-Perelló ,&nbsp;Asunción Chaves-Benito ,&nbsp;Fátima Illán-Gómez ,&nbsp;Andrés Carrillo-Alcaraz ,&nbsp;José Luis Aguayo-Albasini","doi":"10.1016/j.endoen.2016.10.008","DOIUrl":"https://doi.org/10.1016/j.endoen.2016.10.008","url":null,"abstract":"<div><h3>Background and objective</h3><p>Thyroid cancer may be clinically evident as a tumor mass in the neck or as a histopathological incidental finding after thyroid surgery for an apparent benign condition. Our objective was to assess the differences in clinical signs, surgical management, and course between incidental and clinically diagnosed thyroid tumors.</p></div><div><h3>Methods</h3><p>A retrospective study was conducted on patients operated on for benign or malignant thyroid disease from January 2000 to March 2014. Among the 1415 patients who underwent any thyroid surgery, 264 neoplasms were found, of which 170 were incidental. A comparison was made of incidental versus non-incidental carcinomas. Among incidental carcinomas, cases whose indication for surgery was Graves’ disease were compared to those with multinodular goiter.</p></div><div><h3>Results</h3><p>Incidental carcinomas were in earlier stages and required less aggressive surgery. There were no differences in surgical complications between incidental and clinical tumors, but mortality and relapses were markedly higher in non-incidental cancers (4.4% vs 0% and 13.2% vs 4.8% respectively). Carcinomas developing on Graves’ disease showed no differences from all other incidental tumors in terms of complications, mortality, or relapse after surgery.</p></div><div><h3>Conclusions</h3><p>Early stage thyroid cancer has better survival and prognosis after surgical treatment.</p></div>","PeriodicalId":48670,"journal":{"name":"Endocrinologia Y Nutricion","volume":"63 9","pages":"Pages 475-481"},"PeriodicalIF":0.0,"publicationDate":"2016-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.endoen.2016.10.008","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72027624","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
The diabetic paradox: Bone mineral density and fracture in type 2 diabetes 糖尿病悖论:2型糖尿病患者的骨密度与骨折
Pub Date : 2016-11-01 DOI: 10.1016/j.endoen.2016.10.010
Sonsoles Botella Martínez , Nerea Varo Cenarruzabeitia , Javier Escalada San Martin , Amparo Calleja Canelas

Type 2 diabetes mellitus prevalence and morbidity are increasing. Osteoporotic fractures are among the ‘non-classical’ complications of diabetes and been overlooked for a long time, maybe because of their complex diagnostic and therapeutic approach. The usual tools for preventing fragility fractures (such as the fracture risk assessment tool and bone densitometry) underestimate risk of fractures in type 2 diabetic patients. New techniques, such as trabecular bone score or bone turnover markers, could be useful, but greater scientific evidence is required to recommend their use in clinical practice. The special characteristics of their pathophysiology result in decreased bone remodeling with normal or even increased bone mineral density, but with low quality. These changes lead to the occurrence of osteoporotic fractures without evidence of densitometric changes, which could be called ‘the diabetic paradox’.

2型糖尿病的患病率和发病率正在增加。骨质疏松性骨折是糖尿病的“非经典”并发症之一,长期以来一直被忽视,可能是因为其复杂的诊断和治疗方法。预防脆性骨折的常用工具(如骨折风险评估工具和骨密度计)低估了2型糖尿病患者骨折的风险。新技术,如骨小梁评分或骨转换标记物,可能是有用的,但需要更多的科学证据来推荐它们在临床实践中的应用。其病理生理学的特殊特征导致骨重塑减少,骨密度正常甚至增加,但质量较低。这些变化导致骨质疏松性骨折的发生,而没有密度测定变化的证据,这可以被称为“糖尿病悖论”。
{"title":"The diabetic paradox: Bone mineral density and fracture in type 2 diabetes","authors":"Sonsoles Botella Martínez ,&nbsp;Nerea Varo Cenarruzabeitia ,&nbsp;Javier Escalada San Martin ,&nbsp;Amparo Calleja Canelas","doi":"10.1016/j.endoen.2016.10.010","DOIUrl":"https://doi.org/10.1016/j.endoen.2016.10.010","url":null,"abstract":"<div><p>Type 2 diabetes mellitus prevalence and morbidity are increasing. Osteoporotic fractures are among the ‘non-classical’ complications of diabetes and been overlooked for a long time, maybe because of their complex diagnostic and therapeutic approach. The usual tools for preventing fragility fractures (such as the fracture risk assessment tool and bone densitometry) underestimate risk of fractures in type 2 diabetic patients. New techniques, such as trabecular bone score or bone turnover markers, could be useful, but greater scientific evidence is required to recommend their use in clinical practice. The special characteristics of their pathophysiology result in decreased bone remodeling with normal or even increased bone mineral density, but with low quality. These changes lead to the occurrence of osteoporotic fractures without evidence of densitometric changes, which could be called ‘the diabetic paradox’.</p></div>","PeriodicalId":48670,"journal":{"name":"Endocrinologia Y Nutricion","volume":"63 9","pages":"Pages 495-501"},"PeriodicalIF":0.0,"publicationDate":"2016-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.endoen.2016.10.010","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72038278","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 18
Severe systemic type 1 pseudohypoaldosteronism: 5 years of evolution 严重系统性1型假性醛固酮减少症:5年的演变
Pub Date : 2016-11-01 DOI: 10.1016/j.endoen.2016.10.006
Maria Miguel Gomes , Sofia Martins , Olinda Marques , Nicole da Silva , Ana Antunes
{"title":"Severe systemic type 1 pseudohypoaldosteronism: 5 years of evolution","authors":"Maria Miguel Gomes ,&nbsp;Sofia Martins ,&nbsp;Olinda Marques ,&nbsp;Nicole da Silva ,&nbsp;Ana Antunes","doi":"10.1016/j.endoen.2016.10.006","DOIUrl":"https://doi.org/10.1016/j.endoen.2016.10.006","url":null,"abstract":"","PeriodicalId":48670,"journal":{"name":"Endocrinologia Y Nutricion","volume":"63 9","pages":"Pages 502-505"},"PeriodicalIF":0.0,"publicationDate":"2016-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.endoen.2016.10.006","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72038279","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bone mineral density in anorexia nervosa: Only weight and menses recovery? 神经性厌食症的骨密度:只有体重和月经恢复?
Pub Date : 2016-11-01 DOI: 10.1016/j.endoen.2016.10.003
Ignacio Jáuregui-Lobera , Patricia Bolaños-Ríos , Juan Sabaté

Introduction

The study objectives were to analyze the presence of reduced bone mass in a sample of patients with anorexia nervosa (AN) and amenorrhea, to assess Bone Mineral Density (BMD) recovery after having a normal weight is reached and regular menses are resumed, and to predict BMD after a treatment period considering different variables (baseline BMD, baseline and final body mass index (BMI), treatment duration).

Material & Methods

35 patients with AN (mean age 20.57 ± 5.77) were studied at treatment start (T0) and after they had recovered their normal weight and regular menses (T1) in order to measure their BMD using quantitative computed tomography (QCT) of the lumbar spine (L2–L4).

Results

At T0, 2.86% of patients had normal BMD, while a reduced bone mass consistent with osteopenia or with osteoporosis was found in 22.86% and 74.28% of patients respectively. At T1, the percentages were 20%, 20%, and 60% respectively. No significant differences were seen in L2–L3 and mean BMD (L2–L4). A significant difference was however found for L4 (p < 0.05). A positive relationship was seen between final body mass index (BMI) and final BMD in patients with T0–T1 > 11 months, but not when the time period was ≤11 months.

Conclusions

This follow-up study of changes not only in BMD but also in BMI and recovery of menses has clinical relevance from the viewpoint of the day-by-day treatment process. Use of QCT makes the study more relevant because this is a more advanced technique that allows for differentiating trabecular and cortical bone.

引言本研究的目的是分析神经性厌食症(AN)和闭经患者样本中骨量减少的情况,评估达到正常体重和恢复月经后的骨密度(BMD)恢复情况,并考虑不同的变量(基线BMD、基线和最终体重指数(BMI),治疗持续时间);方法对35例AN患者(平均年龄20.57±5.77)在治疗开始时(T0)和恢复正常体重和月经后(T1)进行研究,用腰椎(L2–L4)定量计算机断层扫描(QCT)测量其骨密度,而与骨质减少或骨质疏松症一致的骨量减少分别在22.86%和74.28%的患者中发现。在T1,百分比分别为20%、20%和60%。L2–L3和平均BMD(L2–L4)无显著差异。然而,L4有显著差异(p<;0.05)。T0–T1>;患者的最终体重指数(BMI)和最终BMD之间呈正相关;11个月,但当时间段≤11个月时没有。结论从日常治疗过程的角度来看,对BMD、BMI和月经恢复变化的随访研究具有临床意义。QCT的使用使该研究更具相关性,因为这是一种更先进的技术,可以区分骨小梁和皮质。
{"title":"Bone mineral density in anorexia nervosa: Only weight and menses recovery?","authors":"Ignacio Jáuregui-Lobera ,&nbsp;Patricia Bolaños-Ríos ,&nbsp;Juan Sabaté","doi":"10.1016/j.endoen.2016.10.003","DOIUrl":"https://doi.org/10.1016/j.endoen.2016.10.003","url":null,"abstract":"<div><h3>Introduction</h3><p>The study objectives were to analyze the presence of reduced bone mass in a sample of patients with anorexia nervosa (AN) and amenorrhea, to assess Bone Mineral Density (BMD) recovery after having a normal weight is reached and regular menses are resumed, and to predict BMD after a treatment period considering different variables (baseline BMD, baseline and final body mass index (BMI), treatment duration).</p></div><div><h3>Material &amp; Methods</h3><p>35 patients with AN (mean age 20.57<!--> <!-->±<!--> <!-->5.77) were studied at treatment start (T<sub>0</sub>) and after they had recovered their normal weight and regular menses (T<sub>1</sub>) in order to measure their BMD using quantitative computed tomography (QCT) of the lumbar spine (L2–L4).</p></div><div><h3>Results</h3><p>At T<sub>0</sub>, 2.86% of patients had normal BMD, while a reduced bone mass consistent with osteopenia or with osteoporosis was found in 22.86% and 74.28% of patients respectively. At T<sub>1</sub>, the percentages were 20%, 20%, and 60% respectively. No significant differences were seen in L2–L3 and mean BMD (L2–L4). A significant difference was however found for L4 (<em>p</em> <!-->&lt;<!--> <!-->0.05). A positive relationship was seen between final body mass index (BMI) and final BMD in patients with T<sub>0</sub>–T<sub>1</sub> <!-->&gt;<!--> <!-->11 months, but not when the time period was ≤11 months.</p></div><div><h3>Conclusions</h3><p>This follow-up study of changes not only in BMD but also in BMI and recovery of menses has clinical relevance from the viewpoint of the day-by-day treatment process. Use of QCT makes the study more relevant because this is a more advanced technique that allows for differentiating trabecular and cortical bone.</p></div>","PeriodicalId":48670,"journal":{"name":"Endocrinologia Y Nutricion","volume":"63 9","pages":"Pages 458-465"},"PeriodicalIF":0.0,"publicationDate":"2016-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.endoen.2016.10.003","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72038277","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Endocrinologia Y Nutricion
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1